ESRRA and Obesity: Genetic or pharmacological inhibition of ERRα leads to decreased lipid accumulation, reduced fat mass and resistance to HFD-induced obesity, partly because ERRα-null mice have a lower capacity for lipid absorption by the intestine (84, 91, 100, 113, 114).